AT
Akero Therapeutics Inc
🇺🇸XNAS.AKROUnited StatesHealthcare
$54.65USDunchanged 0.00 (0%)OpenDelayed3:26 PM
Price$54.650.00 (0%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US00973Y1082
- CUSIP
- 00973Y108
Company
- Employees
- 74
- Headquarters
- South San Francisco, United States
- Website
- https://akerotx.com
- CEO
- Dr. Andrew Cheng M.D., Ph.D.
Market
- Shares outstanding
- 82.3M
- Market cap
- $4.5B
Highlights
- Market cap
- $4.5B
- EPS LTM
- -$3.56calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -15.36calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $4K-98.59%down year on year
- Net income
- -$292.82M-23.44%down year on year
- Gross margin
- 50%-49.1%down year on year
- Free cash flow
- -$250.17M-17.65%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.